Orifarm
Buying intent
23 tracked signals | Top 15 topics are below.
Attention by team
LinkedIn activity, by teamWhere Orifarm's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
today
today
17d ago
2d ago
5d ago
17d ago
today
4d ago
16d ago
17d ago
18d ago
17d ago
14d ago
4d ago
5d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Orifarm
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileOrifarm is one of the largest European suppliers of parallel imported and generic pharmaceuticals. We provide high-quality pharmaceuticals at a low cost, and our ambition is to be the number one in making healthcare a better deal while creating value and savings for society and consumers. Internationally, we work together to fulfill our vision, always exploring new business areas to drive Orifarm
Top accounts researching Orifarm
names withheld on the public pageThese are companies whose own people brought up Orifarm unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
129,094 companies · 649,540 people are researching Artificial Intelligence
Orifarm's own team shows 2 signals on this topic. No one outside Orifarm has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Employee Advocacy244 cos · 542 people
- Risk Management13,253 cos · 46,888 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)IT — 1 person
What's been said
public posts mentioning OrifarmUp to 9 public excerpts naming Orifarm from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
The future of pharma? You might just find it… in a box. They say don’t judge a book by its cover. After interpack this week, I’d say… in pharma, the cover actually matters quite a bit. Behind every “simple” box is a lot more than it seems, smart ideas, automation, and plenty of innovation. Great few days full of inspiration, quick chats, and small ideas worth taking back to Orifarm Hostivice. Let’s see which ones turn into real improvements. 😉 #interpack #pharma #packaging #innovation #Orifarm
May 2026We just celebrated 2025 as the best year ever in Orifarm. Therefore, it is an even greater pleasure now to announce that first quarter 2026 is the best quarter ever in Orifarm when it comes to earnings. Thanks to all our great colleagues across Europe and the US who made this result possible !
Apr 2026Today, the sun is shining at Orifarm headquarters in more ways than one. Our first quarter results are in the books. And I’m proud to say that Orifarm is doing better than ever. Q1 2026 was the best quarter in the company’s 30-year history when it comes to earnings. Now that’s what I call a result we can all be proud of. This performance is driven by a strong momentum and team effort across multiple European markets. Strong commercial execution and operational discipline continue to deliver results and strengthen our ability to deliver on our purpose. A sincere thank you from myself and the Executive Management Group to all colleagues across Orifarm, in all 16 countries, for your commitment, professionalism, and daily effort. Let’s keep up the good work! Together, we have secured a strong start to the year. Together, we are strengthening our foundation for growth and delivering on our purpose: to make high-quality affordable medicine available to as many people as possible.
Apr 2026